Saudi Pharmaceutical Industries and Medical Appliances Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Saudi Pharmaceutical Industries and Medical Appliances wird ein jährliches Gewinn- und Umsatzwachstum von 33.5% bzw. 10.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 33.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.9% betragen.
Wichtige Informationen
33.5%
Wachstumsrate der Gewinne
33.2%
EPS-Wachstumsrate
| Pharmaceuticals Gewinnwachstum | 16.6% |
| Wachstumsrate der Einnahmen | 10.1% |
| Zukünftige Eigenkapitalrendite | 11.9% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 25 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Solid Earnings May Rest On Weak Foundations
Nov 24
Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump
Sep 05Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing
Mar 21Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?
Jun 26Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?
Mar 14Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price
Aug 02Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60
May 19One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates
May 12A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Feb 20Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 18Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?
Mar 30Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?
Feb 23What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition
Jan 19
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?
Dec 16Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 2,194 | 185 | 192 | 183 | 5 |
| 12/31/2025 | 1,986 | 145 | 146 | 163 | 5 |
| 12/31/2024 | 1,734 | 114 | 39 | -73 | 1 |
| 9/30/2024 | 1,628 | 23 | -266 | -156 | N/A |
| 6/30/2024 | 1,562 | -18 | -60 | 78 | N/A |
| 3/31/2024 | 1,597 | -40 | 35 | 152 | N/A |
| 12/31/2023 | 1,653 | -20 | -70 | 48 | N/A |
| 9/30/2023 | 1,686 | -76 | -30 | 52 | N/A |
| 6/30/2023 | 1,662 | -78 | -60 | 7 | N/A |
| 3/31/2023 | 1,564 | -142 | -213 | -136 | N/A |
| 12/31/2022 | 1,422 | -152 | -178 | -99 | N/A |
| 9/30/2022 | 1,425 | -94 | -195 | -109 | N/A |
| 6/30/2022 | 1,379 | -42 | -229 | -136 | N/A |
| 3/31/2022 | 1,394 | 38 | -10 | 73 | N/A |
| 12/31/2021 | 1,460 | 30 | 9 | 87 | N/A |
| 9/30/2021 | 1,471 | 57 | -102 | 18 | N/A |
| 6/30/2021 | 1,532 | 117 | -145 | -24 | N/A |
| 3/31/2021 | 1,534 | 110 | -172 | -23 | N/A |
| 12/31/2020 | 1,555 | 130 | -165 | 10 | N/A |
| 9/30/2020 | 1,521 | -114 | 44 | 278 | N/A |
| 6/30/2020 | 1,491 | -153 | 241 | 505 | N/A |
| 3/31/2020 | 1,518 | -365 | -37 | 275 | N/A |
| 12/31/2019 | 1,487 | -434 | 18 | 352 | N/A |
| 9/30/2019 | 1,743 | -163 | -164 | 138 | N/A |
| 6/30/2019 | 1,626 | -204 | -461 | -165 | N/A |
| 3/31/2019 | 1,566 | 6 | -271 | 10 | N/A |
| 12/31/2018 | 1,503 | 74 | -355 | -74 | N/A |
| 9/30/2018 | 1,313 | 66 | -280 | -42 | N/A |
| 6/30/2018 | 1,366 | 61 | N/A | 25 | N/A |
| 3/31/2018 | 1,375 | 85 | N/A | 103 | N/A |
| 12/31/2017 | 1,386 | 139 | N/A | 155 | N/A |
| 9/30/2017 | 1,315 | 274 | N/A | 205 | N/A |
| 6/30/2017 | 1,295 | 296 | N/A | 118 | N/A |
| 3/31/2017 | 1,329 | 289 | N/A | -21 | N/A |
| 12/31/2016 | 1,259 | 277 | N/A | -94 | N/A |
| 9/30/2016 | 1,448 | 124 | N/A | -281 | N/A |
| 6/30/2016 | 1,499 | 149 | N/A | -134 | N/A |
| 3/31/2016 | 1,595 | 347 | N/A | -53 | N/A |
| 12/31/2015 | 1,705 | 357 | N/A | -38 | N/A |
| 9/30/2015 | 1,604 | 457 | N/A | 115 | N/A |
| 6/30/2015 | 1,562 | 465 | N/A | 44 | N/A |
| 3/31/2015 | 1,500 | 325 | N/A | 12 | N/A |
| 12/31/2014 | 1,470 | 317 | N/A | 43 | N/A |
| 9/30/2014 | 1,424 | 283 | N/A | -94 | N/A |
| 6/30/2014 | 1,381 | 279 | N/A | -79 | N/A |
| 3/31/2014 | 1,351 | 295 | N/A | 79 | N/A |
| 12/31/2013 | 1,311 | 267 | N/A | 54 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: 2070Das prognostizierte Gewinnwachstum (33.5% pro Jahr) liegt über der Sparquote (14.7%).
Ertrag vs. Markt: 2070Die Erträge des Unternehmens (33.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt SA (6.5% pro Jahr).
Hohe Wachstumserträge: 2070Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: 2070Die Einnahmen des Unternehmens (10.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt SA (-0.2% pro Jahr).
Hohe Wachstumseinnahmen: 2070Die Einnahmen des Unternehmens (10.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: 2070Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.9%).